Predict your next investment

HEALTHCARE | Biotechnology
periness.com

See what CB Insights has to offer

Stage

Other Investors | Alive

About Peri-Ness

Peri-Ness is a biotechnology company focusing on addressing the problem of male infertility. The company's product is a systemic protein-based drug for treatment of male sub-fertility.

Peri-Ness Headquarter Location

Israel

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Peri-Ness Patents

Peri-Ness has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/20/2012

10/6/2015

Molecular biology, Transcription factors, Cell biology, Signal transduction, Human proteins

Grant

Application Date

12/20/2012

Grant Date

10/6/2015

Title

Related Topics

Molecular biology, Transcription factors, Cell biology, Signal transduction, Human proteins

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.